WEST PHARMACEUTICAL SERVICES INC - COM (WST)

Historical Portfolio Holders from Q1 2014 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
63.5 M
Holdings value Q1 2024
$25 B
Value change Q1 2024
-$208 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
745
Number of buys Q1 2024
362
Number of sells Q1 2024
-343
Average buys Q1 2024 %
+0.026%
Average sells Q1 2024 %
-0.003%
CUSIP
955306105
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 63.5 M $25 B -$208 M $395.71 745
2023 Q4 67.6 M $23.7 B +$203 M $352.12 756
2023 Q3 66.9 M $25.1 B +$166 M $375.21 742
2023 Q2 66.8 M $25.5 B -$805 M $382.47 711
2023 Q1 65.8 M $22.7 B +$354 M $346.47 672
2022 Q4 68.8 M $16.2 B +$15.8 M $235.35 616
2022 Q3 67.8 M $16.7 B -$360 M $246.08 603
2022 Q2 67.9 M $20.4 B -$170 M $302.37 627
2022 Q1 67.9 M $27.8 B -$2.82 M $410.71 685
2021 Q4 67.4 M $31.5 B +$704 M $469.01 708
2021 Q3 66.1 M $27.9 B -$686 M $424.54 660
2021 Q2 68.4 M $24.4 B +$165 M $359.10 626
2021 Q1 67.7 M $19 B +$70.2 M $281.78 578
2020 Q4 68.6 M $19.4 B +$199 M $283.31 573
2020 Q3 66 M $18.1 B -$198 M $274.90 558
2020 Q2 67.8 M $15.5 B +$456 M $227.17 510
2020 Q1 66.4 M $10.1 B -$43.4 M $152.25 444
2019 Q4 67.4 M $10.1 B +$89.9 M $150.33 429
2019 Q3 67 M $9.51 B -$51 M $141.82 395
2019 Q2 67.2 M $8.41 B +$89.4 M $125.15 360
2019 Q1 67.7 M $7.47 B -$154 M $110.20 365
2018 Q4 69.3 M $6.79 B +$37 M $98.03 342
2018 Q3 68.7 M $8.48 B +$105 M $123.47 346
2018 Q2 69 M $6.85 B -$60.5 M $99.29 314
2018 Q1 70.2 M $6.2 B +$35.3 M $88.29 318
2017 Q4 69.6 M $6.87 B -$50.7 M $98.67 329
2017 Q3 69.8 M $6.72 B +$236 M $96.26 298
2017 Q2 67.2 M $6.36 B +$125 M $94.52 305
2017 Q1 65.6 M $5.36 B +$388 M $81.61 283
2016 Q4 66 M $5.6 B +$86 M $84.83 277
2016 Q3 66.1 M $4.92 B +$54.1 M $74.50 270
2016 Q2 65.1 M $4.95 B -$130 M $75.88 279
2016 Q1 65.2 M $4.52 B +$73.9 M $69.32 238
2015 Q4 65.6 M $3.95 B -$8.12 M $60.22 241
2015 Q3 67.5 M $3.65 B +$3.55 M $54.12 245
2015 Q2 66.6 M $3.87 B +$17.9 M $58.08 216
2015 Q1 67.2 M $4.04 B +$108 M $60.21 211
2014 Q4 65.6 M $3.49 B -$15.4 M $53.24 221
2014 Q3 66.2 M $2.96 B +$86.2 M $44.76 212
2014 Q2 64.5 M $2.72 B +$34.7 M $42.18 219
2014 Q1 63.6 M $2.8 B +$37.3 M $44.05 222